Tuesday, November 27, 2018 4:17:38 PM
Every bit of stock issued has been accounted for. As I have repeatedly posted, unaudited financials are available since 2012. See below for the information available for any that want to know facts about the company. I have posted it and questioned why ROTH should be held to a different standard than any other company that posts unaudited results and therefore is on otcmarkets.
Name date and price paid along with other required information are listed for shares sold or issued for services in each quarterly supplemental for the 2 years prior. I note that since the 2012 annual report (earliest listed filing on otcmarkets.com) which lists back to 4/15/2010, just before ROTH purchased Sucanon rights from BIOHF and Rieveley family, when 127,500,000 shares were outstanding, all share sales and prices have been listed up to the current period. Let's be clear that what is required and what other companies do is release ongoing sales for the 2 years prior in the filings. What others have asked is to list information for ALL shares outstanding, which would include any sales and public trading since inception of a trading market for ROTH shares, which is not done by any company period. That is why despite me identifying this issue and challenging the clearly unreasonable request, there has been no posting of any example listed company that actually lists in real time all sales, prices, and owners.
As an investor that has never sold any shares of ROTH, the posting of verifiably false information about the company and product is disturbing and unethical at the very least. If the situation were that dire, there would be no need to manufacture false information to embellish in an attempt to 'prove' a predetermined false conclusion.
Jacob J. Rosenblum on what every lawyer knows.
“If the facts are against you, hammer the law. If the law is against you, hammer the facts. If the fact and the law are against you, hammer opposing counsel."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM